Breast cancer
Nuvastatic® Phase III Trial for Fatigue in Triple-Negative Breast Cancer
Where to go
3 hospitals in India taking patients for this trial.
Registry summary (technical)
The goal of this clinical trial is to evaluate whether Nuvastatic 300 mg capsules can reduce cancer-related fatigue in adult patients with colon cancer undergoing first-line chemotherapy. The main questions it aims to answer are: * Does Nuvastatic 300 mg capsules significantly reduce cancer-related fatigue compared to placebo? * Is Nuvastatic 300 mg capsules safe and well tolerated in this patient population? Researchers will compare Nuvastatic 300 mg capsules vs placebo to see if Nuvastatic 300 capsule improves fatigue scores and maintains an acceptable safety profile. Participants will: …
Sponsor: Natureceuticals Sdn Bhd
NCT07669467 on ClinicalTrials.gov
Last updated on the registry 25 Aug 2026 · read by us 20 Oct 2026